These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18814292)

  • 1. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha).
    Phue JN; Lee SJ; Trinh L; Shiloach J
    Biotechnol Bioeng; 2008 Nov; 101(4):831-6. PubMed ID: 18814292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode.
    Borja GM; Meza Mora E; Barrón B; Gosset G; Ramírez OT; Lara AR
    Microb Cell Fact; 2012 Sep; 11():132. PubMed ID: 22992433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced plasmid DNA production by enzyme-controlled glucose release and an engineered Escherichia coli.
    Ramírez EA; Velázquez D; Lara AR
    Biotechnol Lett; 2016 Apr; 38(4):651-7. PubMed ID: 26696535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing.
    Gonçalves GA; Prather KL; Monteiro GA; Carnes AE; Prazeres DM
    J Biotechnol; 2014 Sep; 186():119-27. PubMed ID: 24995846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering E. coli for improved microaerobic pDNA production.
    Jaén KE; Velazquez D; Delvigne F; Sigala JC; Lara AR
    Bioprocess Biosyst Eng; 2019 Sep; 42(9):1457-1466. PubMed ID: 31079222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of growth conditions on plasmid DNA production.
    Silva F; Passarinha L; Sousa F; Queiroz JA; Domingues FC
    J Microbiol Biotechnol; 2009 Nov; 19(11):1408-14. PubMed ID: 19996695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering of Escherichia coli strains for plasmid biopharmaceutical production: scale-up challenges.
    Gonçalves GA; Prather KL; Monteiro GA; Prazeres DM
    Vaccine; 2014 May; 32(24):2847-50. PubMed ID: 24598722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth medium selection and its economic impact on plasmid DNA production.
    Danquah MK; Forde GM
    J Biosci Bioeng; 2007 Dec; 104(6):490-7. PubMed ID: 18215636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of Cra in regulating acetate excretion and osmotic tolerance in E. coli K-12 and E. coli B at high density growth.
    Son YJ; Phue JN; Trinh LB; Lee SJ; Shiloach J
    Microb Cell Fact; 2011 Jun; 10():52. PubMed ID: 21718532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of growth rate on plasmid DNA production and metabolic performance of engineered Escherichia coli strains.
    Wunderlich M; Taymaz-Nikerel H; Gosset G; Ramírez OT; Lara AR
    J Biosci Bioeng; 2014 Mar; 117(3):336-42. PubMed ID: 24012107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of plasmid DNA yields during fed-batch culture of a fruR-knockout Escherichia coli strain.
    Ow DS; Yap MG; Oh SK
    Biotechnol Appl Biochem; 2009 Jan; 52(Pt 1):53-9. PubMed ID: 18380624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering of bacterial strains and vectors for the production of plasmid DNA.
    Bower DM; Prather KL
    Appl Microbiol Biotechnol; 2009 Apr; 82(5):805-13. PubMed ID: 19205691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing PCR fragment stability and protein yields in a cell-free system with genetically modified Escherichia coli extracts.
    Michel-Reydellet N; Woodrow K; Swartz J
    J Mol Microbiol Biotechnol; 2005; 9(1):26-34. PubMed ID: 16254443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo creation of MG1655-derived E. coli strains specifically designed for plasmid DNA production.
    Gonçalves GA; Prazeres DM; Monteiro GA; Prather KL
    Appl Microbiol Biotechnol; 2013 Jan; 97(2):611-20. PubMed ID: 22885693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RecA-mediated excision repair: a novel mechanism for repairing DNA lesions at sites of arrested DNA synthesis.
    Bichara M; Pinet I; Lambert IB; Fuchs RP
    Mol Microbiol; 2007 Jul; 65(1):218-29. PubMed ID: 17581130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segregated growth kinetics of Escherichia coli DH5α-NH36 in exponential-fed perfusion culture for pDNA vaccine production.
    Munguía-Soto R; García-Rendón A; Garibay-Escobar A; Guerrero-Germán P; Tejeda-Mansir A
    Biotechnol Appl Biochem; 2015; 62(6):795-805. PubMed ID: 25556882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing strategies to increase plasmid DNA production in Escherichia coli DH5α using batch culture.
    Islas-Lugo F; Vega-Estrada J; Alvis CA; Ortega-López J; Del Carmen Montes-Horcasitas M
    J Biotechnol; 2016 Sep; 233():66-73. PubMed ID: 27374404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excision of Anabaena PCC 7120 nifD element in Escherichia coli: Growth kinetics and RecA regulated xisA expression and DNA rearrangement.
    Karunakaran R; Mehta O; Kunjadia P; Apte S; Nareshkumar G
    Bioresour Technol; 2008 Jul; 99(11):4551-8. PubMed ID: 17765537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.
    El-Attar LM; Scott S; Goh S; Good L
    Vaccine; 2012 Feb; 30(9):1702-9. PubMed ID: 22212129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of glucose import capacity in Escherichia coli: physiologic consequences and utility for improving DNA vaccine production.
    Fuentes LG; Lara AR; Martínez LM; Ramírez OT; Martínez A; Bolívar F; Gosset G
    Microb Cell Fact; 2013 May; 12():42. PubMed ID: 23638701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.